Pentagon Requires Testosterone Screenings for Troops Over 30

Secretary of Defense Pete Hegseth announced on July 15, 2026, that the Pentagon will require annual testosterone deficiency screenings for all active-duty service members aged 30 and older, with younger troops able to volunteer. The screenings will be added to periodic health assessments, and those flagged as deficient can opt for testosterone replacement therapy (TRT). This policy expands a military culture shift already seen in Hegseth's grooming standards enforcement and anti-diversity directives, and echoes the Project 2025 playbook's focus on 'warrior ethos' and traditional gender roles.

The policy lacks evidence that widespread asymptomatic screening improves combat readiness, and may lead to overdiagnosis and unnecessary medicalization of normal age-related hormonal changes. The military already screens for specific health threats tied to operational demands; adding a broad hormone screen opens the door to expensive treatments, potential side effects, and privacy concerns. Notably, the policy applies to women as well, despite testosterone's different role in female physiology.

The framing of this as a readiness measure is belied by its timing and tone: Hegseth announced it on social media as part of a broader cultural campaign, not a medical directive. The policy could also pressure troops to pursue TRT to avoid appearing 'deficient,' potentially straining the Defense Health Agency's budget and diverting resources from evidence-based care. Critics note that this move prioritizes a political vision of military strength over actual health outcomes.